Todor Totev

13PUBLICATIONS
33CO-AUTHORS
Psychological methodology, design and analysisCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPharmacogenomicsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 12, 2026
Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis.

|Apr 01, 2026
Symptom Burden and Healthcare Resource Use in Patients With Claudin 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective Review.

Matheus Sewastjanow-Silva, Mok Oh, Lawrence Chang

|Mar 23, 2026
Real-World Clinical Effectiveness and Migraine-Related Healthcare Resource Utilization in Patients Initiating Fremanezumab in Germany and the United Kingdom.

Axel Heinze, Shazia K Afridi, Todor I Totev

|Jun 13, 2025
Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study.

Maen Abdelrahim, Abdullah Esmail, Richard D Kim

|Sep 14, 2022
Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey.

Maryia Zhdanava, H Lynn Starr, Todor I Totev

|Aug 26, 2022
Assessment of the Impact of a Meningitis/Encephalitis Panel on Hospital Length of Stay: A Systematic Review and Meta-Analysis.

Kyle D Hueth, Philippe Thompson-Leduc, Todor I Totev

Pageof 3

Frequent Collaborators

2 joint publications

Mei Sheng Duh

2 joint publications

Beilei Cai

2 joint publications

H Lynn Starr

2 joint publications

Dominic Pilon